Trial Profile
A Randomized, Open-label, Single Dose Crossover Study to Compare the Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan (Valsartan) Film-coated Tablet 160 mg and Crestor (Rosuvastatin) 20 mg in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosuvastatin/valsartan (Primary) ; Rosuvastatin; Valsartan
- Indications Hyperlipidaemia; Hypertension
- Focus Pharmacokinetics
- Sponsors LG Life Sciences
- 10 Aug 2013 New trial record